Atiprimod
Atiprimod
Atiprimod (pronounced: a-ti-pri-mod) is a synthetic small molecule, primarily classified as an antineoplastic agent. It is currently under investigation for its potential use in the treatment of various types of cancer.
Etymology
The term "Atiprimod" is a coined name for this specific compound. The exact etymology is not known, as it is common with many pharmaceutical substances.
Usage
Atiprimod is being studied for its potential use in the treatment of neuroendocrine tumors, multiple myeloma, and carcinoid tumors. It is believed to work by inhibiting the growth of cancer cells and by inducing apoptosis, or programmed cell death.
Related Terms
- Antineoplastic agent: A substance that inhibits the growth and spread of cancerous cells.
- Neuroendocrine tumor: A type of tumor that begins in the hormone-producing cells of the body's neuroendocrine system.
- Multiple myeloma: A type of blood cancer that begins in the plasma cells, a type of white blood cell.
- Carcinoid: A slow-growing type of neuroendocrine tumor, usually found in the gastrointestinal system.
- Apoptosis: The process of programmed cell death that occurs in multicellular organisms.
See Also
External links
- Medical encyclopedia article on Atiprimod
- Wikipedia's article - Atiprimod
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski